Skip to content

This site uses cookies for analytics and to improve your experience. By clicking Accept, you consent to our use of cookies. Learn more in our privacy policy.

  • Home
    • Superinfection Therapy
    • Value Proposition
    • Exit Strategy
  • About Us
    • Brief history of HepC Inc
    • Leadership
  • Clinical Development
    • Preclinical evidence
    • Manufacturing
    • Clinical Evidence
    • Lead Clinical Option for Rapid Registration
  • Collaboration and Support
    • A Doctor, A Patient, A Breakthrough
    • A Call to Action
  • Blog/News
    • Updates on research progress
    • Repurposing IBDV as a versatile, off-the-shelf antiviral tool is possible!
    • Publications
    • Experts who have worked with us or supported the IBDV drug candidate
  • Contact Us

Author: admin

© 2025 Copyright  HepC Therapeutics Inc. – Superinfection  I © Designed by Weblap4U.eu